Navigating Executive Orders and DOJ Memos That Threaten Criminal Prosecution
FDA Law Blog
MAY 26, 2025
118, 129 (2007) (quoting Abbott Labs v. Attorneys Offices to use the False Claims Act (FCA) to investigate the submission of false claims to federal healthcare programs for non-covered services related to radical gender experimentation. MedImmune, Inc. Genentech, Inc., Gardner , 387 U.S. 136, 152 (1967)). The memo also instructs U.S.
59 
Let's personalize your content